Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Gross Profit (2016 - 2025)

Historic Gross Profit for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $22.0 million.

  • Xtant Medical Holdings' Gross Profit rose 3486.23% to $22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.5 million, marking a year-over-year increase of 1906.16%. This contributed to the annual value of $68.2 million for FY2024, which is 2298.48% up from last year.
  • According to the latest figures from Q3 2025, Xtant Medical Holdings' Gross Profit is $22.0 million, which was up 3486.23% from $24.3 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Gross Profit ranged from a high of $24.3 million in Q2 2025 and a low of $7.2 million during Q3 2021
  • For the 5-year period, Xtant Medical Holdings' Gross Profit averaged around $13.4 million, with its median value being $12.5 million (2023).
  • Per our database at Business Quant, Xtant Medical Holdings' Gross Profit crashed by 2224.26% in 2021 and then soared by 10632.07% in 2023.
  • Xtant Medical Holdings' Gross Profit (Quarter) stood at $7.7 million in 2021, then increased by 7.94% to $8.3 million in 2022, then skyrocketed by 106.32% to $17.1 million in 2023, then dropped by 6.49% to $16.0 million in 2024, then surged by 37.24% to $22.0 million in 2025.
  • Its Gross Profit stands at $22.0 million for Q3 2025, versus $24.3 million for Q2 2025 and $20.2 million for Q1 2025.